Henry Schein (NASDAQ:HSIC) Posts Earnings Results, Beats Expectations By $0.06 EPS

Henry Schein (NASDAQ:HSIC) released its quarterly earnings results on Tuesday. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.16 by $0.06, Briefing.com reports. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The business’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.32 EPS. Henry Schein updated its FY 2024 guidance to 4.740-4.820 EPS.

Henry Schein Stock Up 1.5 %

Henry Schein stock opened at $70.01 on Thursday. The firm has a market capitalization of $8.87 billion, a P/E ratio of 25.93, a P/E/G ratio of 2.08 and a beta of 0.87. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. Henry Schein has a twelve month low of $62.05 and a twelve month high of $82.63. The stock’s fifty day simple moving average is $70.59 and its 200-day simple moving average is $69.78.

Analyst Ratings Changes

HSIC has been the topic of a number of research analyst reports. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday. JPMorgan Chase & Co. decreased their target price on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. Evercore ISI increased their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. UBS Group decreased their price objective on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. Finally, Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. One analyst has rated the stock with a sell rating, six have assigned a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Henry Schein presently has a consensus rating of “Hold” and a consensus target price of $77.50.

Insider Activity at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.14% of the stock is currently owned by company insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.